Ondine Biomedical names Alan Thomas as interim chief financial officer

Related news

Ondine Biomedical Inc on Friday appointed Alan Thomas as its non-board interim chief financial officer, effective immediately.

The Vancouver, Canada-based life sciences company said Michael Behlke ‘is stepping down from his role as CFO & [chief operating officer] for personal reasons’.

Thomas was previously CFO at Maximus Canada Inc, a division of Virginia-based government services company Maximus Inc.

Interim CFO Thomas said: ‘Ondine is entering an exciting phase of development, with growing momentum behind its breakthrough technology.

‘I’m looking forward to working with the team to help drive the company’s strategic and financial objectives forward.’

Ondine said chief operating officer duties will be assumed by the current executive management.

Shares in Ondine Biomedical were down 3.9% at 8.65 pence in London on Friday afternoon.

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.